Pharmaron Beijing Co Ltd Class A 300759
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 26.82
- Price/Sales
- 3.44
- Dividend Yield (Trailing)
- 0.90%
- Dividend Yield (Forward)
- 0.90%
- Total Yield
- 0.90%
Company Profile
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 20,342
- Website
- https://www.pharmaron.com
Comparables
Valuation
|
Metric
|
300759
|
688399
|
688253
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.82 | — | 18.56 |
Price/Book Value | 3.06 | 1.36 | 2.56 |
Price/Sales | 3.44 | 11.86 | 7.57 |
Price/Cash Flow | 15.29 | 672.94 | 14.52 |
Price/Earnings
300759
688399
688253
Financial Strength
|
Metric
|
300759
|
688399
|
688253
|
|---|---|---|---|
Quick Ratio | 1.41 | 5.79 | 15.40 |
Current Ratio | 1.81 | 6.10 | 15.84 |
Interest Coverage | 10.01 | −45.10 | 2,238.82 |
Quick Ratio
300759
688399
688253
Profitability
|
Metric
|
300759
|
688399
|
688253
|
|---|---|---|---|
Return on Assets (Normalized) | 5.12% | −8.31% | 12.17% |
Return on Equity (Normalized) | 9.91% | −9.66% | 13.13% |
Return on Invested Capital (Normalized) | 6.74% | −10.10% | 12.68% |
Return on Assets
300759
688399
688253
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Kytblksgg | Cxys | $554.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Lnwjzsdfy | Gjqfxks | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Ypkwshdng | Jfdbg | $114.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Khymcdsq | Lfbys | $35.2 Bil | |||
| argenx SE ADR
ARGX
| Gcdydzqs | Glhc | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Jvvptyk | Hmrz | $28.0 Bil | |||
| Moderna Inc
MRNA
| Kywnmgzwq | Zhmr | $24.6 Bil | |||
| United Therapeutics Corp
UTHR
| Qdpqsfqv | Gtxl | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Rjmljfwrw | Wyrjvp | $13.4 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Ngfrpryww | Pbzmzy | $12.6 Bil |
United States